Literature DB >> 20443997

Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies.

S Prey1, C Paul, V Bronsard, E Puzenat, P-A Gourraud, S Aractingi, F Aubin, M Bagot, B Cribier, P Joly, D Jullien, M Le Maitre, M-A Richard-Lallemand, J-P Ortonne.   

Abstract

INTRODUCTION: Many epidemiological studies have associated psoriasis with an increased risk of coronary artery disease, resulting from a higher prevalence of cardiovascular risk factors in psoriasis patients compared with unmatched controls. However, the results of epidemiological studies vary depending upon the populations studied. The aim of this systemic review was to evaluate the risk of diabetes, hypertension, dyslipidaemia and obesity in adults with plaque psoriasis. In addition, we assessed the relationship between the risk of cardiovascular risk factors and psoriasis severity.
METHODS: A systematic search was performed on Pubmed, Cochrane and Embase databases, using the key-words 'psoriasis', 'diabetes', 'hypertension', 'high blood pressure', 'dyslipidaemia', 'metabolic syndrome' and 'obesity', during the period from 1980 to June 2009.
RESULTS: The initial literature search identified 353 articles. The final selection included 18 cross-sectional case-control studies. An increased risk of metabolic syndrome was observed in psoriatic patients (OR = 1.3-5.92), and a trend for a higher risk of obesity (OR = 1.18-5.49), especially in patients with severe psoriasis. For hypertension, hypertriglyceridaemia, and diabetes, the association was not significant in all studies. DISCUSSION: There was important heterogeneity in study design preventing from pooling results. Most often lifestyle factors such as smoking, alcohol consumption, physical activities were not taken into account.
CONCLUSION: There is an increased risk of obesity and metabolic syndrome in psoriasis. For hypertension, diabetes and dyslipidaemia no consistency was found across studies. Prospective epidemiological studies with thorough recording of cardiovascular risk factors are required in psoriasis patients.

Entities:  

Mesh:

Year:  2010        PMID: 20443997     DOI: 10.1111/j.1468-3083.2009.03564.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  25 in total

1.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.

Authors:  Andrew Blauvelt; Marc Brown; Kenneth B Gordon; Arthur Kavanaugh; Craig T Leonardi; Eggert Stockfleth; Bruce Strober; Neil A Swanson; George Martin
Journal:  J Clin Aesthet Dermatol       Date:  2013-09

2.  Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006.

Authors:  Thorvardur Jon Love; Abrar A Qureshi; Elizabeth Wood Karlson; Joel M Gelfand; Hyon K Choi
Journal:  Arch Dermatol       Date:  2010-12-20

3.  Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges.

Authors:  Sukhmani Pannu; David Rosmarin
Journal:  Am J Clin Dermatol       Date:  2021-02-15       Impact factor: 7.403

4.  Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis.

Authors:  William C Ports; Rana Fayyad; David A DeMicco; Rachel Laskey; Robert Wolk
Journal:  Clin Drug Investig       Date:  2017-08       Impact factor: 2.859

5.  Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

Authors:  K Abuabara; R S Azfar; D B Shin; A L Neimann; A B Troxel; J M Gelfand
Journal:  Br J Dermatol       Date:  2010-09       Impact factor: 9.302

Review 6.  Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.

Authors:  Wolf-Henning Boehncke; Sandra Boehncke
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

7.  Association of inflammatory disease and long-term outcomes among young adults with myocardial infarction: the Mass General Brigham YOUNG-MI Registry.

Authors:  Brittany Weber; David W Biery; Avinainder Singh; Sanjay Divakaran; Adam N Berman; Wanda Y Wu; Jenifer M Brown; Jon Hainer; Khurram Nasir; Katherine Liao; Deepak L Bhatt; Marcelo F Di Carli; Ron Blankstein
Journal:  Eur J Prev Cardiol       Date:  2022-03-11       Impact factor: 7.804

Review 8.  Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies.

Authors:  Ehrin J Armstrong; Caitlin T Harskamp; April W Armstrong
Journal:  J Am Heart Assoc       Date:  2013-04-04       Impact factor: 5.501

9.  Study on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis.

Authors:  G Márquez Balbás; M Sánchez Regaña; P Umbert Millet
Journal:  Clin Cosmet Investig Dermatol       Date:  2011-06-20

10.  Cardiovascular comorbiditiy in psoriasis.

Authors:  Gurcharan Singh; Simran Pal Singh Aneja
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.